These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36834216)

  • 1. Annual Direct Cost and Cost-Drivers of Systemic Lupus Erythematosus: A Multi-Center Cross-Sectional Study from CSTAR Registry.
    Wang H; Li M; Zou K; Wang Y; Jia Q; Wang L; Zhao J; Wu C; Wang Q; Tian X; Wang Y; Zeng X
    Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36834216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct and indirect costs for systemic lupus erythematosus in Sweden. A nationwide health economic study based on five defined cohorts.
    Jönsen A; Hjalte F; Willim M; Carlsson KS; Sjöwall C; Svenungsson E; Leonard D; Bengtsson C; Rantapää-Dahlqvist S; Pettersson S; Gunnarsson I; Zickert A; Gustafsson JT; Rönnblom L; Petersson IF; Bengtsson AA; Nived O
    Semin Arthritis Rheum; 2016 Jun; 45(6):684-90. PubMed ID: 26743074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cost of systemic lupus erythematosus for adult patients with active and treated disease in France (LUCIE study)].
    Amoura Z; Deligny C; Pennaforte JL; Hamidou M; Blanco P; Hachulla E; Pourrat J; Queyrel V; Garofano A; Maurel F; Levy-Bachelot L; Boucot I
    Rev Med Interne; 2014 Nov; 35(11):700-8. PubMed ID: 24630588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cost of care of systemic lupus erythematosus (SLE) in the UK: annual direct costs for adult SLE patients with active autoantibody-positive disease.
    Khamashta MA; Bruce IN; Gordon C; Isenberg DA; Ateka-Barrutia O; Gayed M; Donatti C; Guillermin AL; Foo J; Perna A
    Lupus; 2014 Mar; 23(3):273-83. PubMed ID: 24356612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthcare Costs and Utilization for Patients With Systemic Lupus Erythematosus in China: A National Claims Database Study.
    He X; Lloyd E; Cooper S; Li L; Chauhan D; Juliao P; Quasny H; Bao C
    Value Health Reg Issues; 2023 Sep; 37():88-96. PubMed ID: 37379801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease severity and economic burden in Japanese patients with systemic lupus erythematosus: A retrospective, observational study.
    Tanaka Y; Mizukami A; Kobayashi A; Ito C; Matsuki T
    Int J Rheum Dis; 2018 Aug; 21(8):1609-1618. PubMed ID: 30146745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chinese SLE Treatment and Research group (CSTAR) registry: V. gender impact on Chinese patients with systemic lupus erythematosus.
    Zhang S; Su J; Li X; Zhang X; Liu S; Wu L; Ma L; Bi L; Zuo X; Sun L; Huang C; Zhao J; Li M; Zeng X;
    Lupus; 2015 Oct; 24(12):1267-75. PubMed ID: 25972364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Annual direct medical cost of active systemic lupus erythematosus in five European countries.
    Doria A; Amoura Z; Cervera R; Khamastha MA; Schneider M; Richter J; Guillemin F; Kobelt G; Maurel F; Garofano A; Perna A; Murray M; Schmitt C; Boucot I
    Ann Rheum Dis; 2014 Jan; 73(1):154-60. PubMed ID: 23264339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment patterns and medical cost of systemic lupus erythematosus patients in Japan: a retrospective claims database study.
    Miyazaki C; Sruamsiri R; Mahlich J; Jung W
    J Med Econ; 2020 Jul; 23(7):786-799. PubMed ID: 32149541
    [No Abstract]   [Full Text] [Related]  

  • 10. Incremental direct medical costs of systemic lupus erythematosus patients in the years preceding diagnosis: A general population-based study.
    McCormick N; Marra CA; Sadatsafavi M; Aviña-Zubieta JA
    Lupus; 2018 Jul; 27(8):1247-1258. PubMed ID: 29665755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Healthcare utilization and cost of systemic lupus erythematosus in a US managed care health plan.
    Garris C; Jhingran P; Bass D; Engel-Nitz NM; Riedel A; Dennis G
    J Med Econ; 2013; 16(5):667-77. PubMed ID: 23425294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costs associated with severe and nonsevere systemic lupus erythematosus in Canada.
    Clarke AE; Urowitz MB; Monga N; Hanly JG
    Arthritis Care Res (Hoboken); 2015 Mar; 67(3):431-6. PubMed ID: 25185936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chinese SLE Treatment and Research group (CSTAR) registry: II. Prevalence and risk factors of pulmonary arterial hypertension in Chinese patients with systemic lupus erythematosus.
    Li M; Wang Q; Zhao J; Li Z; Ye Z; Li C; Li X; Zhu P; Wang Z; Zheng Y; Li X; Zhang M; Tian Z; Liu Y; He J; Zhang F; Zhao Y; Zeng X;
    Lupus; 2014 Sep; 23(10):1085-91. PubMed ID: 24651670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chinese SLE Treatment and Research group (CSTAR) registry: I. Major clinical characteristics of Chinese patients with systemic lupus erythematosus.
    Li M; Zhang W; Leng X; Li Z; Ye Z; Li C; Li X; Zhu P; Wang Z; Zheng Y; Li X; Zhang M; Zhang F; Zhao Y; Zeng X;
    Lupus; 2013 Oct; 22(11):1192-9. PubMed ID: 23963101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct medical costs and their predictors in South Korean patients with systemic lupus erythematosus.
    Park SY; Joo YB; Shim J; Sung YK; Bae SC
    Rheumatol Int; 2015 Nov; 35(11):1809-15. PubMed ID: 26254885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct cost of management and treatment of active systemic lupus erythematosus and its flares in Spain: the LUCIE Study.
    Cervera R; Rúa-Figueroa I; Gil-Aguado A; Sabio JM; Pallarés L; Hernández-Pastor LJ; Iglesias M
    Rev Clin Esp (Barc); 2013 Apr; 213(3):127-37. PubMed ID: 23398815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chinese Systemic Lupus Erythematosus Treatment and Research Group (CSTAR) Registry XI: gender impact on long-term outcomes.
    Zhang S; Ye Z; Li C; Li Z; Li X; Wu L; Liu S; Zuo X; Zhu P; Wang Z; Wang Y; Wang Z; Zhao J; Wang Q; Tian X; Li M; Zeng X
    Lupus; 2019 Apr; 28(5):635-641. PubMed ID: 30939980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drivers of cost and health-related quality of life in patients with systemic lupus erythematosus (SLE): a Swedish nationwide study based on patient reports.
    Bexelius C; Wachtmeister K; Skare P; Jönsson L; Vollenhoven Rv
    Lupus; 2013 Jul; 22(8):793-801. PubMed ID: 23761101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospitalization of patients with systemic lupus erythematosus is a major cause of direct and indirect healthcare costs.
    Anandarajah AP; Luc M; Ritchlin CT
    Lupus; 2017 Jun; 26(7):756-761. PubMed ID: 27831537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healthcare Utilization and Costs of Systemic Lupus Erythematosus by Disease Severity in the United States.
    Murimi-Worstell IB; Lin DH; Kan H; Tierce J; Wang X; Nab H; Desta B; Alexander GC; Hammond ER
    J Rheumatol; 2021 Mar; 48(3):385-393. PubMed ID: 32611669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.